ANAPTYSBIO INC
For the period ended Jun 30, 2024. Filed Aug 5, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 5, 2024
ANAB$46.45+1.9%Stored close · as of Nov 6, 2026
Contents
Consolidated Balance Sheets as of June, 2024 and December 31, 2023
Consolidated Balance Sheets
(in thousands, except par value data)
| June 30, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $71,821 | $35,965 |
| Receivables from collaborative partners | 9,007 | 6,851 |
| Short-term investments | 278,983 | 354,939 |
| Prepaid expenses and other current assets | 7,539 | 9,080 |
| Total current assets | 367,350 | 406,835 |
| Property and equipment, net | 1,833 | 2,098 |
| Operating lease right-of-use assets | 15,291 | 16,174 |
| Long-term investments | 42,646 | 27,026 |
| Other long-term assets | 256 | 256 |
| Total assets | $427,376 | $452,389 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $4,890 | $4,698 |
| Accrued expenses | 33,680 | 30,967 |
| Current portion of operating lease liability | 1,850 | 1,777 |
| Total current liabilities | 40,420 | 37,442 |
| Liability related to sale of future royalties | 361,981 | 310,807 |
| Operating lease liability, net of current portion | 15,096 | 16,037 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at June 30, 2024 and December 31, 2023, respectively | — | — |
| Common stock, $0.001 par value, 500,000 shares authorized, 27,434 shares and 26,597 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively | 27 | 27 |
| Additional paid in capital | 714,959 | 702,969 |
| Accumulated other comprehensive loss | (415) | (797) |
| Accumulated deficit | (704,692) | (614,096) |
| Total stockholders’ equity | 9,879 | 88,103 |
| Total liabilities and stockholders’ equity | $427,376 | $452,389 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.